Silvercrest Asset Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
AIC
ACM
Silvercrest Asset Management's SOPH Position: Q3 2026 in Review
Silvercrest Asset Management reduced its SOPHiA GENETICS (SOPH) stake by 0.32% in Q3 2026, selling an estimated $32.4K and leaving 1,423,965 shares worth $11.9M. The position accounts for 0.08% of the portfolio, ranked #307.
Silvercrest Asset Management first reported a position in SOPH in Q2 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.
- Silvercrest Asset Management held 1,423,965 shares of SOPHiA GENETICS worth $11.9M as of Q3 2026.
- Silvercrest Asset Management sold 4,505 SOPHiA GENETICS shares in Q3 2026, an estimated $32.4K.
- SOPHiA GENETICS made up 0.08% of Silvercrest Asset Management's portfolio in Q3 2026, its #307 holding.
- Silvercrest Asset Management first reported a position in SOPHiA GENETICS in Q2 2026 and has held it in 2 quarters since.
- 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.
Based on Silvercrest Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.